Christine Maclean

Quality Assurance Specialist at Biofrontera - Woburn, MA, US

Christine Maclean's Contact Details
HQ
781-245-1325
Location
Company
Biofrontera
Christine Maclean's Company Details
Biofrontera logo, Biofrontera contact details

Biofrontera

Woburn, MA, US • 100 - 249 Employees
Major Drugs

Biofrontera AG is a biopharmaceutical company specializing in the development and sale of dermatological drugs and medical cosmetics. The Germany-based company develops and markets innovative products for the care, protection and treatment of the skin. The company's lead product is the combination of Ameluz®, a topical prescription drug, and medical device BF-RhodoLED® for the photodynamic therapy of certain superficial skin cancers and their precursors. Ameluz® has been marketed in the EU since 2012 and in the United States since May 2016. In the EU, the company also sells the dermocosmetics series Belixos®, which offers specialized care for damaged or diseased skin. Biofrontera is the first German pharmaceutical company to receive a centralized European and a US approval for a drug developed in-house. The Biofrontera Group was founded in 1997 and is listed on the Frankfurt Stock Exchange (ticker symbol: B8F) and on the US NASDAQ (ticker symbol: BFRA).

N/A
Details about Biofrontera
Frequently Asked Questions about Christine Maclean
Christine Maclean currently works for Biofrontera Group.
Christine Maclean's role at Biofrontera Group is Quality Assurance Specialist.
Christine Maclean's email address is ***@biofrontera.com. To view Christine Maclean's full email address, please signup to ConnectPlex.
Christine Maclean works in the Pharmaceuticals industry.
Christine Maclean's colleagues at Biofrontera are Lynda M., Bert McCarley, Andrew Goodlatte, Jennifer Lindgren, Kerry McCormack, Branden Testa, Laura Keating and others.
Christine Maclean's phone number is 781-245-1325
See more information about Christine Maclean